Medicine Man Technologies (SHWZ)
OTHER OTC:SHWZ
Holding SHWZ?
Track your performance easily

Medicine Man Technologies (SHWZ) Income Statement

138 Followers

Medicine Man Technologies Income Statement

Last quarter (Q3 2023), Medicine Man Technologies's total revenue was $42.94M, an increase of Infinity% from the same quarter last year. In Q3, Medicine Man Technologies's net income was $-1.87M. See Medicine Man Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 138.61M$ 172.45M$ 142.95M$ 116.93M$ 24.00M$ 10.62M
Cost of Revenue
----$ 17.23M$ 7.62M
Gross Profit
----$ 6.77M$ 3.00M
Operating Expense
----$ 29.68M$ 21.87M
Operating Income
----$ -22.90M$ -13.46M
Net Non Operating Interest Income Expense
----$ -41.46K$ -160.19K
Other Income Expense
----$ 2.63M$ -3.93M
Pretax Income
$ -13.64M$ -14.81M$ -3.57M$ 18.92M$ -20.32M$ -17.56M
Tax Provision
$ 18.89M$ 19.74M$ 14.90M$ 4.40M$ -899.11K$ -582.93K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 36.96M$ -42.70M$ -26.27M$ 7.17M$ -19.42M$ -16.98M
Basic EPS
$ 1.78M$ -0.66$ -0.49$ 0.17$ -0.47$ -0.50
Diluted EPS
$ -0.73$ -0.66$ -0.49$ -0.06$ -0.47$ -0.50
Basic Average Shares
$ 257.21M$ 64.54M$ 53.64M$ 43.34M$ 41.22M$ 33.74M
Diluted Average Shares
$ 302.99M$ 64.54M$ 53.64M$ 101.37M$ 41.22M$ 33.74M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
----$ 46.90M$ 29.48M
Net Income From Continuing And Discontinued Operation
$ 41.83M$ -34.55M$ -18.47M$ 14.52M$ -19.42M$ -16.98M
Normalized Income
$ 2.89M-$ 9.88M-$ -21.90M$ -13.17M
Interest Expense
$ 96.21M-$ 30.14M$ -7.01M$ 41.46K-
EBIT
$ -17.29M$ 17.26M-$ 18.92M$ -20.27M$ -13.46M
EBITDA
$ 3.13M$ 48.40M-$ 27.49M$ -19.80M$ -13.40M
Currency in USD

Medicine Man Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis